Artificial Heart Lung Machines Market

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the ?pump?, and does the work of the heart and lungs during the operation.

Artificial Heart Lung Machines Market contains market size and forecasts of Artificial Heart Lung Machines in global, including the following market information:

Global Artificial Heart Lung Machines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Artificial Heart Lung Machines Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Artificial Heart Lung Machines companies in 2021 (%)

The global Artificial Heart Lung Machines market was valued at 286 million in 2021 and is projected to reach US$ 369.7 million by 2028, at a CAGR of 3.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Roller Pump HLM Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Artificial Heart Lung Machines include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica and Tianjin Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Heart Lung Machines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Artificial Heart Lung Machines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Artificial Heart Lung Machines Market Segment Percentages, by Type, 2021 (%)

Single Roller Pump HLM

Double Roller Pump HLM

Global Artificial Heart Lung Machines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Artificial Heart Lung Machines Market Segment Percentages, by Application, 2021 (%)

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Global Artificial Heart Lung Machines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Artificial Heart Lung Machines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Artificial Heart Lung Machines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Artificial Heart Lung Machines revenues share in global market, 2021 (%)

Key companies Artificial Heart Lung Machines sales in global market, 2017-2022 (Estimated), (Units)

Key companies Artificial Heart Lung Machines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical